SciELO - Scientific Electronic Library Online

 
vol.50 número2Metabolic syndrome and juvenile idiopathic arthritisInfliximab in relapsing polychondritis índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista Brasileira de Reumatologia

versión impresa ISSN 0482-5004

Resumen

NOBRE, Christiane Aguiar et al. Anti-TNF therapy in renal amyloidosis in refractory rheumatoid arthritis: a new therapeutic perspective. Rev. Bras. Reumatol. [online]. 2010, vol.50, n.2, pp.205-208. ISSN 0482-5004.  http://dx.doi.org/10.1590/S0482-50042010000200009.

Amyloidosis is a heterogeneous group of diseases characterized by extracellular deposits of a material composed of aggregates of amyloid - a poorly coupled protein - far from the site of synthesis, causing target organ dysfunction and clinical disease. Systemic amyloidosis A (AA), secondary to infections and chronic inflammation, especially rheumatoid arthritis (RA), is the most common form of amyloid deposition. Treatment of AA consists in the control or resolution of the baseline condition. The objective of the present study was to report a case of secondary renal amyloidosis in a patient with long-term refractory RA who presented sustained clinical improvement after the use of anti-TNFα (etanercept).

Palabras clave : renal amyloidosis; rheumatoid arthritis; anti-TNFα; etanercept.

        · resumen en Portugués     · texto en Portugués | Inglés     · Inglés ( pdf epdf ) | Portugués ( pdf epdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons